Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotarix (PCV-free) co-administered with IPV in Chinese infants
CTR20240406Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of human rotavirus RIX4414 strain vaccine, inactivated poliomyelitis vaccine (Sabin strains) in rotaviral diarrhea, poliomyelitis, sponsored by GSK. Started Feb 2024; status: completed.
02
Drugs
human rotavirus RIX4414 strain vaccineinactivated poliomyelitis vaccine (Sabin strains)
03
Conditions
rotaviral diarrheapoliomyelitis
Beyond the preview
Go deeper on CTR20240406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240406.